We are live on ! Find out more
DRIO icon

DarioHealth

20 hedge funds and large institutions have $5.31M invested in DarioHealth in 2019 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more funds holding

Funds holding: 1320 (+7)

13% more capital invested

Capital invested by funds: $4.7M → $5.31M (+$611K)

0% more ownership

Funds ownership: 0.04%0.05% (+0%)

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
20
Holders Change
+7
Holders Change %
+53.85%
% of All Funds
0.43%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
2
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

DRIO Hedge Fund Activity: Q1 2019 in Review

20 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in DarioHealth (DRIO) for Q1 2019, worth a combined $5.31M — up 13% from $4.7M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new DRIO positions and 0 closed out — a net gain of 7 holders — while 2 added to existing stakes and 3 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $358K. The largest seller was BlackRock, cutting an estimated $2.08K.

  • 20 institutional investors held DarioHealth (DRIO) as of Q1 2019, up from 13 in Q4 2018.
  • Funds reported $5.31M of DarioHealth stock for Q1 2019, up 13% quarter-over-quarter.
  • 7 funds opened new DarioHealth positions in Q1 2019 and 0 closed out, a net change of +7 holders.
  • The largest DarioHealth buyer in Q1 2019 was Goldman Sachs, an estimated $358K added.
  • The largest DarioHealth seller in Q1 2019 was BlackRock, an estimated $2.08K sold.

Based on aggregated 13F filings for Q1 2019.